PEP/NEWS — Peptide intel. Daily.

GLP-1 DRUGS NOW STUDIED ACROSS 6+ LIVER DISEASE SUBTYPES BEYOND DIABETESAPOE2 CARRIERS SHOW MEASURABLY LOWER RATES OF NEURONAL SENESCENCE IN NEW DATACREATINE IS STORED IN THE BRAIN AS WELL AS MUSCLE — ABOUT 5% OF TOTAL BODY STORES158 ALZHEIMER'S DRUGS ARE IN ACTIVE CLINICAL TRIALS AS OF 2026 — UP FROM 141 IN 2024SLEEP UNDER 7 HOURS RANKS 3RD STRONGEST PREDICTOR OF SHORTER LIFE IN COUNTY-LEVEL DATATIRZEPATIDE OUTPERFORMED THIAZOLIDINEDIONES ON LIVER OUTCOMES IN MULTI-CENTER REAL-WORLD COHORTEPITALON RESEARCH SPANS THREE STRUCTURAL VARIANTS WITH DIFFERING STABILITY PROFILESMUSCLE LOSS ON GLP-1 AGONISTS TRACKS WITH CALORIC DEFICIT — NOT DRUG MECHANISM ITSELF GLP-1 DRUGS NOW STUDIED ACROSS 6+ LIVER DISEASE SUBTYPES BEYOND DIABETESAPOE2 CARRIERS SHOW MEASURABLY LOWER RATES OF NEURONAL SENESCENCE IN NEW DATACREATINE IS STORED IN THE BRAIN AS WELL AS MUSCLE — ABOUT 5% OF TOTAL BODY STORES158 ALZHEIMER'S DRUGS ARE IN ACTIVE CLINICAL TRIALS AS OF 2026 — UP FROM 141 IN 2024SLEEP UNDER 7 HOURS RANKS 3RD STRONGEST PREDICTOR OF SHORTER LIFE IN COUNTY-LEVEL DATATIRZEPATIDE OUTPERFORMED THIAZOLIDINEDIONES ON LIVER OUTCOMES IN MULTI-CENTER REAL-WORLD COHORTEPITALON RESEARCH SPANS THREE STRUCTURAL VARIANTS WITH DIFFERING STABILITY PROFILESMUSCLE LOSS ON GLP-1 AGONISTS TRACKS WITH CALORIC DEFICIT — NOT DRUG MECHANISM ITSELF

Last updated May 16, 2026 — I read this morning's peptide research and picked the items that mattered. Fresh brief tomorrow.

◤ Top story · Peter Attia
PETER ATTIA CALLS PEPTIDES 'LEGITIMATE BUT NARROW' IN WIDE-RANGING AMA...

*Attia separates signal from noise: which peptides have real evidence, which don't.*

Peter Attia

Featured Briefs

▶ Video · Peptide-anchored

IS CJC-1295 IPAMORELIN SAFE

Is CJC-1295 & Ipamorelin actually safe, or am I overlooking risks like sourcing, side effects, and lack of medical oversight? In this video, I break down how I evaluate peptide safety, what the evidence and clinical experience show, and why

Regan Archibald
▶ Video

THE SARMS TIER LIST THAT ENDS DIFFERENTLY

Steroid Tierlist: https://youtu.be/Qn4N2RTkgKU Peptide Tierlist: https://youtu.be/vZX0U0owGT0 SARMs were marketed as the “safe shortcut” to muscle growth. More gains. Fewer side effects. No needles. No problems. But does the science actu

Dr Alex Tatem

More Headlines